Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT06363526
Enrolling by invitation Not applicable

Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.

NCT06363526 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-02-05
Last updated
2025-04-01

Condition(s) studied

Duchenne Muscular DystrophyBecker Muscular DystrophyMuscular Dystrophy

Investigational drug(s) / intervention(s)

Digital respiratory intervention program

Digital respiratory intervention program: A 4 times a week for a period of 5 weeks will be done, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. Moreover, an intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery. The intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as as well as with a weekly follow-up using WhatsApp or Zoom as forms of communication, or a telephone call to ensure correct follow-up of the intervention program. Moreover, YouTube videos, own videos prepared by the physiotherapy will be used to help optimally resolve doubts that arise when carrying out the program by video call.

Study summary

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

Eligibility

Sex
ALL
Min age
5 Years
Max age
20 Years
Healthy volunteers
No
Inclusion Criteria: * Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen. * Aged between 5 and 20 years. * Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20. Exclusion Criteria: * Patients who present associated heart disease. * Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded. * Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Rocío Martín-Valero Málaga Spain

More University of Malaga trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06363526 on ClinicalTrials.gov ↗ ← All trials in Spain